Daveen chopra edwards lifesciences
WebMar 25, 2024 · The firm has a 50-day moving average price of $78.66 and a 200 day moving average price of $79.15. Edwards Lifesciences Co. has a twelve month low of $67.13 and a twelve month high of $131.10. The ... WebDaveen Chopra is VP/Gen Mgr:TMTT Business at Edwards Lifesciences Corp. See Daveen Chopra's compensation, career history, education, & memberships.
Daveen chopra edwards lifesciences
Did you know?
WebView Daveen Chopra’s profile on LinkedIn, the world’s largest professional community. ... Corporate Vice President and General Manager at … WebApr 11, 2024 · Insider Buying and Selling at Edwards Lifesciences. In other news, VP Daveen Chopra sold 4,000 shares of the business’s stock in a transaction dated Tuesday, January 17th. The shares were sold ...
WebApr 13, 2024 · 19 analysts have issued 1 year price objectives for Edwards Lifesciences' stock. Their EW share price forecasts range from $66.00 to $110.00. On average, they … WebApr 14, 2024 · Signaturefd LLC reduced its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Get Rating) by 16.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. ... In related news, VP Daveen Chopra sold 4,000 shares of the business's stock in a transaction that occurred …
WebApr 13, 2024 · Insider Activity. In other news, VP Daveen Chopra sold 4,000 shares of the company’s stock in a transaction dated Wednesday, February 15th. The stock was sold … WebApr 10, 2024 · The company has a market cap of $50.84 billion, a PE ratio of 34.38, a P/E/G ratio of 4.88 and a beta of 1.02. The stock has a fifty day moving average price of $79.45 and a 200 day moving average price of $78.26. Edwards Lifesciences Co. has a 1-year low of $67.13 and a 1-year high of $131.10. Edwards Lifesciences ( NYSE:EW - Get …
WebJul 15, 2024 · IRVINE, Calif., July 15, 2024 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received approval from the U.S. Food and Drug Administration (FDA) for the KONECT RESILIA aortic valved conduit (AVC), the first …
WebOct 28, 2024 · For full year 2024, we expect total Edwards sales will be negatively impacted by foreign exchange and be at the low end of our previous range of $5.35 billion to $5.55 billion. We anticipate ... the place umhlangaWebJul 15, 2024 · IRVINE, Calif., July 15, 2024 - Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and … the place uaeWebJan 15, 2024 · Daveen Chopra, Edwards Lifesciences: Degenerative mitral valve regurgitation is a type of heart disease. It’s commonly caused by mitral valve prolapse, a … the place value for the number 3 in 3 487WebApr 12, 2024 · Edwards Lifesciences (NYSE:EW - Get Rating) last posted its quarterly earnings data on Tuesday, January 31st. The medical research company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.61 by $0.03. ... Also, VP Daveen Chopra sold 4,000 shares of the stock in a transaction on Tuesday, … the place value of 6 in 5.236 isWebApr 14, 2024 · Also, VP Daveen Chopra sold 4,000 shares of Edwards Lifesciences stock in a transaction on Tuesday, January 17th. The shares were sold at an average price of $78.00, for a total value of $312,000.00. the place vacanciesWebMay 26, 2024 · The estimated net worth of Daveen Chopra is at least $1.53 million as of March 15th, 2024. Mr. Chopra owns 18,911 shares of Edwards Lifesciences stock … the place uscWebApr 9, 2024 · In other Edwards Lifesciences news, VP Daveen Chopra sold 4,000 shares of the business's stock in a transaction on Wednesday, February 15th. The shares were … the place ucf